» Articles » PMID: 37319029

Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023

Citing Articles

A bivalent COVID-19 mRNA vaccine elicited broad immune responses and protection against Omicron subvariants infection.

Liu J, Wang L, Kurtesi A, Budylowski P, Potts K, Menon H NPJ Vaccines. 2025; 10(1):4.

PMID: 39788981 PMC: 11718203. DOI: 10.1038/s41541-025-01062-8.


High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 and CD8 memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patients.

Coulon P, Prakash S, Dhanushkodi N, Srivastava R, Zayou L, Tifrea D Front Immunol. 2024; 15:1343716.

PMID: 38605956 PMC: 11007208. DOI: 10.3389/fimmu.2024.1343716.


Oral Agents and SARS-CoV-2 Vaccine Effectiveness against Severe COVID-19 Omicron Events in Patients Requiring Maintenance Dialysis.

Manley H, Li N, Hsu C, Weiner D, Miskulin D, Harford A Kidney360. 2024; 5(3):445-450.

PMID: 38297444 PMC: 11000726. DOI: 10.34067/KID.0000000000000373.


Long-Term Trends in the Protection Against Severe Courses of COVID-19 by Vaccination.

Beyerlein A, Weigert M, Katz K, Kuchenhoff H, Hartl W Dtsch Arztebl Int. 2023; 120(51-52):873-878.

PMID: 37963066 PMC: 10859745. DOI: 10.3238/arztebl.m2023.0230.

References
1.
Fast H, Zell E, Patel Murthy B, Murthy N, Meng L, Gibbs Scharf L . Booster and Additional Primary Dose COVID-19 Vaccinations Among Adults Aged ≥65 Years - United States, August 13, 2021-November 19, 2021. MMWR Morb Mortal Wkly Rep. 2021; 70(50):1735-1739. PMC: 8675661. DOI: 10.15585/mmwr.mm7050e2. View

2.
Johnson A, Linde L, Ali A, DeSantis A, Shi M, Adam C . COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022. MMWR Morb Mortal Wkly Rep. 2023; 72(6):145-152. PMC: 9925136. DOI: 10.15585/mmwr.mm7206a3. View

3.
Silk B, Scobie H, Duck W, Palmer T, Ahmad F, Binder A . COVID-19 Surveillance After Expiration of the Public Health Emergency Declaration - United States, May 11, 2023. MMWR Morb Mortal Wkly Rep. 2023; 72(19):523-528. PMC: 10208372. DOI: 10.15585/mmwr.mm7219e1. View

4.
DeCuir J, Surie D, Zhu Y, Gaglani M, Ginde A, Douin D . Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19-Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period - IVY Network, 19 U.S. States, February 1, 2022-January.... MMWR Morb Mortal Wkly Rep. 2023; 72(17):463-468. DOI: 10.15585/mmwr.mm7217a3. View

5.
Link-Gelles R, Weber Z, Reese S, Payne A, Gaglani M, Adams K . Estimates of Bivalent mRNA Vaccine Durability in Preventing COVID-19-Associated Hospitalization and Critical Illness Among Adults with and Without Immunocompromising Conditions - VISION Network, September 2022-April 2023. MMWR Morb Mortal Wkly Rep. 2023; 72(21):579-588. PMC: 10231940. DOI: 10.15585/mmwr.mm7221a3. View